• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压识别和管理的当前趋势:2017 年 ACC/AHA 高血压指南发布后,来自国家健康和营养调查(NHANES)的见解。

Current Trends in Hypertension Identification and Management: Insights from the National Health and Nutrition Examination Survey (NHANES) Following the 2017 ACC/AHA High Blood Pressure Guidelines.

机构信息

Department of Medicine Jersey Shore University Medical Center Neptune City NJ.

Division of Cardiology Jersey Shore University Medical Center Neptune City NJ.

出版信息

J Am Heart Assoc. 2024 Apr 16;13(8):e034322. doi: 10.1161/JAHA.123.034322. Epub 2024 Apr 2.

DOI:10.1161/JAHA.123.034322
PMID:38563377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11262485/
Abstract

BACKGROUND

Hypertension is a global health issue associated with increased cardiovascular morbidity and mortality. This study aimed to investigate contemporary hypertension identification and management trends following the 2017 American College of Cardiology/American Heart Association guidelines.

METHODS AND RESULTS

Data from the National Health and Nutrition Examination Survey conducted from 2017 to 2020 were analyzed. Participants between 20 and 79 years of age were included. Participants were stratified into different treatment groups based on indication and guideline adherence. Descriptive statistics were used to compare medication use, diagnosis rates, and blood pressure control. A total of 265 402 026 people met the inclusion criteria, of which 19.0% (n=50 349 209) were undergoing guideline antihypertensive management. In the guideline antihypertensive management group, a single antihypertensive class was used to treat 45.7% of participants, and 55.2% had uncontrolled blood pressure. Participants not undergoing guideline antihypertensive management qualified for primary prevention in 11.5% (n=24 741 999) of cases and for secondary prevention in 2.4% (n=5 070 044) of cases; of these, 66.3% (n=19 774 007) did not know they may have hypertension and were not on antihypertensive medication.

CONCLUSIONS

Adherence to guidelines for antihypertensive management is suboptimal. Over half of patients undergoing guideline treatment had uncontrolled blood pressure. One-third of qualifying participants may not be receiving treatment. Education and medical management were missing for 2 in 3 qualifying participants. Addressing these deficiencies is crucial for improving blood pressure control and reducing cardiovascular event outcomes.

摘要

背景

高血压是一个全球性的健康问题,与心血管发病率和死亡率的增加有关。本研究旨在调查 2017 年美国心脏病学会/美国心脏协会指南发布后,当代高血压识别和管理趋势。

方法和结果

分析了 2017 年至 2020 年进行的国家健康和营养检查调查的数据。纳入年龄在 20 至 79 岁之间的参与者。根据适应证和指南依从性将参与者分为不同的治疗组。使用描述性统计比较药物使用、诊断率和血压控制情况。共有 265402026 人符合纳入标准,其中 19.0%(n=50349209)正在接受指南推荐的降压治疗。在指南推荐的降压治疗组中,45.7%的参与者使用单一降压药物治疗,55.2%的患者血压未得到控制。未接受指南推荐降压治疗的患者,11.5%(n=24741999)符合一级预防适应证,2.4%(n=5070044)符合二级预防适应证;其中 66.3%(n=19774007)不知道自己可能患有高血压,也没有服用降压药物。

结论

高血压管理指南的依从性不理想。接受指南治疗的患者中,超过一半的患者血压未得到控制。符合条件的患者中有三分之一可能未接受治疗。三分之一可能符合条件的患者未接受治疗。三分之二的符合条件的患者可能没有接受教育和药物管理。解决这些不足对于改善血压控制和降低心血管事件结局至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0c/11262485/90a9edb5cfef/JAH3-13-e034322-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0c/11262485/b9f342579b52/JAH3-13-e034322-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0c/11262485/90a9edb5cfef/JAH3-13-e034322-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0c/11262485/b9f342579b52/JAH3-13-e034322-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0c/11262485/90a9edb5cfef/JAH3-13-e034322-g002.jpg

相似文献

1
Current Trends in Hypertension Identification and Management: Insights from the National Health and Nutrition Examination Survey (NHANES) Following the 2017 ACC/AHA High Blood Pressure Guidelines.高血压识别和管理的当前趋势:2017 年 ACC/AHA 高血压指南发布后,来自国家健康和营养调查(NHANES)的见解。
J Am Heart Assoc. 2024 Apr 16;13(8):e034322. doi: 10.1161/JAHA.123.034322. Epub 2024 Apr 2.
2
Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.2017ACC/AHA 高血压指南对美国人口的潜在影响。
Circulation. 2018 Jan 9;137(2):109-118. doi: 10.1161/CIRCULATIONAHA.117.032582. Epub 2017 Nov 13.
3
Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.2017 年 ACC/AHA 高血压指南对美国人口的潜在影响。
J Am Coll Cardiol. 2018 Jan 16;71(2):109-118. doi: 10.1016/j.jacc.2017.10.073. Epub 2017 Nov 13.
4
Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry.2017 年美国心脏病学会/美国心脏协会高血压指南对当代实践的潜在影响:来自 NCDR PINNACLE 注册的横断面分析。
J Am Heart Assoc. 2022 Jun 7;11(11):e024107. doi: 10.1161/JAHA.121.024107. Epub 2022 Jun 3.
5
Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them.2017 年美国心脏病学会/美国心脏协会高血压指南对中国成年人的潜在影响及应对策略。
BMC Cardiovasc Disord. 2020 May 19;20(1):237. doi: 10.1186/s12872-020-01523-z.
6
Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.采用 2017 年美国心脏病学会/美国心脏协会血压指南可预防潜在的心血管疾病事件。
Circulation. 2019 Jan 2;139(1):24-36. doi: 10.1161/CIRCULATIONAHA.118.035640.
7
A Comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes.美国心脏病学会/美国心脏协会血压指南 2017 版与 2017 年美国糖尿病协会美国成年人糖尿病与高血压立场声明比较。
Diabetes Care. 2018 Nov;41(11):2322-2329. doi: 10.2337/dc18-1307. Epub 2018 Aug 27.
8
Cardiovascular Disease and Mortality in Adults Aged ≥60 Years According to Recommendations by the American College of Cardiology/American Heart Association and American College of Physicians/American Academy of Family Physicians.根据美国心脏病学会/美国心脏协会和美国医师学院/美国家庭医师学会的建议,≥60 岁成年人的心血管疾病和死亡率。
Hypertension. 2019 Feb;73(2):327-334. doi: 10.1161/HYPERTENSIONAHA.118.12291.
9
Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.将生物标志物纳入 2017 ACC/AHA 高血压指南指导的抗高血压药物分配风险评估中:一项汇总队列分析。
Circulation. 2019 Dec 17;140(25):2076-2088. doi: 10.1161/CIRCULATIONAHA.119.043337. Epub 2019 Nov 11.
10
Population impact of different hypertension management guidelines based on the prospective population-based Heinz Nixdorf Recall study.基于前瞻性人群研究 Heinz Nixdorf Recall 对不同高血压管理指南的人群影响。
BMJ Open. 2021 Feb 17;11(2):e039597. doi: 10.1136/bmjopen-2020-039597.

引用本文的文献

1
The association between A Body Shape Index and total bone mineral density in adults aged 20 to 59 NHANES 2011 to 2018.2011年至2018年美国国家健康与营养检查调查(NHANES)中20至59岁成年人的体型指数与总骨密度之间的关联。
Medicine (Baltimore). 2025 May 30;104(22):e42652. doi: 10.1097/MD.0000000000042652.
2
Twenty years population-based trends in prevalence, awareness, treatment, and control of hypertension in Geneva, Switzerland.瑞士日内瓦20年来基于人群的高血压患病率、知晓率、治疗率和控制率趋势
Prev Med Rep. 2025 Apr 1;53:103055. doi: 10.1016/j.pmedr.2025.103055. eCollection 2025 May.
3
Prevalence of Patient Knowledge Gaps Regarding the Purpose of Their Cardiometabolic Medications.

本文引用的文献

1
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes.在 2 型糖尿病合并慢性肾脏病患者中用非奈利酮治疗血压和心肾结局。
Hypertension. 2022 Dec;79(12):2685-2695. doi: 10.1161/HYPERTENSIONAHA.122.19744. Epub 2022 Oct 12.
2
National Health and Nutrition Examination Survey, 2017-March 2020 Prepandemic File: Sample Design, Estimation, and Analytic Guidelines.2017 年-2020 年 3 月全国健康与营养调查预流行期文件:抽样设计、估计和分析指南。
Vital Health Stat 1. 2022 May(190):1-36.
3
Advancing Equity in Blood Pressure Control: A Response to the Surgeon General's Call-to-Action.
患者对其心脏代谢药物用途的知识缺口患病率。
J Gen Intern Med. 2025 Feb 10. doi: 10.1007/s11606-025-09407-8.
4
Non-linear Association of CAR with all-Cause and Cardiovascular Mortality in Coronary Heart Disease: A Retrospective Cohort Study from NHANES.CAR 与冠心病全因和心血管死亡率的非线性关联:来自 NHANES 的回顾性队列研究。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241271382. doi: 10.1177/10760296241271382.
5
Blood Lead Mediates the Relationship between Biological Aging and Hypertension: Based on the NHANES Database.血液铅含量介导了生物老化与高血压之间的关系:基于 NHANES 数据库。
Nutrients. 2024 Jul 5;16(13):2144. doi: 10.3390/nu16132144.
推进血压控制公平性:对卫生总监呼吁行动的回应。
Am J Hypertens. 2022 Mar 8;35(3):217-224. doi: 10.1093/ajh/hpab187.
4
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.老年高血压患者强化血压控制试验。
N Engl J Med. 2021 Sep 30;385(14):1268-1279. doi: 10.1056/NEJMoa2111437. Epub 2021 Aug 30.
5
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study.比较 ACE(血管紧张素转换酶)抑制剂和血管紧张素受体阻滞剂的一线疗效和安全性:一项多国队列研究。
Hypertension. 2021 Sep;78(3):591-603. doi: 10.1161/HYPERTENSIONAHA.120.16667. Epub 2021 Jul 26.
6
Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.种族/民族特异性降压药物类别变化与第八版美国联合委员会报告中委员会成员报告之间的关联。
JAMA Netw Open. 2020 Nov 2;3(11):e2025127. doi: 10.1001/jamanetworkopen.2020.25127.
7
Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review.与单一制剂相比,复方制剂是否能提高患者的依从性?一项系统评价。
Pharmaceutics. 2020 Feb 22;12(2):190. doi: 10.3390/pharmaceutics12020190.
8
Communication skills training for physicians improves health literacy and medical outcomes among patients with hypertension: a randomized controlled trial.医师沟通技巧培训可提高高血压患者的健康素养和医疗结局:一项随机对照试验。
BMC Health Serv Res. 2020 Jan 23;20(1):60. doi: 10.1186/s12913-020-4901-8.
9
Polypill for Cardiovascular Disease Prevention in an Underserved Population.用于服务不足人群心血管疾病预防的复方药。
N Engl J Med. 2019 Sep 19;381(12):1114-1123. doi: 10.1056/NEJMoa1815359.
10
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.多酚丸用于心血管疾病一级和二级预防的效果(PolyIran):一项实用、整群随机试验。
Lancet. 2019 Aug 24;394(10199):672-683. doi: 10.1016/S0140-6736(19)31791-X.